Natural Beauty Bio-Technology Limited (HK:0157)
:0157
Want to see HK:0157 full AI Analyst Report?
Total Valuation
Natural Beauty Bio-Technology has a market cap or net worth of HK$910.96M. The enterprise value is HK$1.13B.
Market CapHK$910.96M
Enterprise ValueHK$1.13B
Share Statistics
Natural Beauty Bio-Technology has 2,002,101,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,002,101,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Natural Beauty Bio-Technology’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.60%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)2.60%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee994.15K
Profits Per Employee19.52K
Employee Count542
Asset Turnover0.58
Inventory Turnover2.58
Valuation Ratios
The current PE Ratio of Natural Beauty Bio-Technology is 86.3. Natural Beauty Bio-Technology’s PEG ratio is -0.84.
PE Ratio86.3
PS Ratio1.82
PB Ratio2.07
Price to Fair Value2.07
Price to FCF-10.45
Price to Operating Cash Flow-35.57
PEG Ratio-0.84
Income Statement
In the last 12 months, Natural Beauty Bio-Technology had revenue of 538.83M and earned 10.58M in profits. Earnings per share was <0.01.
Revenue538.83M
Gross Profit293.34M
Operating Income23.18M
Pretax Income11.82M
Net Income10.58M
EBITDA57.78M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was -25.66M and capital expenditures -68.25M, giving a free cash flow of -93.91M billion.
Operating Cash Flow-25.66M
Free Cash Flow-93.91M
Free Cash Flow per Share-0.05
Dividends & Yields
Natural Beauty Bio-Technology pays an annual dividend of HK$0.024, resulting in a dividend yield of ―
Dividend Per ShareHK$0.024
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.01
52-Week Price Change-7.14%
50-Day Moving Average0.48
200-Day Moving Average0.51
Relative Strength Index (RSI)31.80
Average Volume (3m)13.87K
Important Dates
Natural Beauty Bio-Technology upcoming earnings date is Aug 5, 2026, TBA (Confirmed).
Last Earnings DateMar 10, 2026
Next Earnings DateAug 5, 2026
Ex-Dividend Date―
Financial Position
Natural Beauty Bio-Technology as a current ratio of 1.11, with Debt / Equity ratio of 67.37%
Current Ratio1.11
Quick Ratio0.81
Debt to Market Cap0.31
Net Debt to EBITDA3.72
Interest Coverage Ratio2.21
Taxes
In the past 12 months, Natural Beauty Bio-Technology has paid 1.24M in taxes.
Income Tax1.24M
Effective Tax Rate0.10
Enterprise Valuation
Natural Beauty Bio-Technology EV to EBITDA ratio is 20.70, with an EV/FCF ratio of -12.74.
EV to Sales2.22
EV to EBITDA20.70
EV to Free Cash Flow-12.74
EV to Operating Cash Flow-46.62
Balance Sheet
Natural Beauty Bio-Technology has HK$112.12M in cash and marketable securities with HK$319.30M in debt, giving a net cash position of -HK$207.18M billion.
Cash & Marketable SecuritiesHK$112.12M
Total DebtHK$319.30M
Net Cash-HK$207.18M
Net Cash Per Share-HK$0.10
Tangible Book Value Per ShareHK$0.24
Margins
Gross margin is 54.44%, with operating margin of 4.30%, and net profit margin of 1.96%.
Gross Margin54.44%
Operating Margin4.30%
Pretax Margin2.19%
Net Profit Margin1.96%
EBITDA Margin10.72%
EBIT Margin5.08%
Analyst Forecast
The average price target for Natural Beauty Bio-Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast52.36%
EPS Growth Forecast―